| Important Links | Patient Prescription Record |
| SPECIMEN REQUIREMENTS | |
| Container Type | Random urine |
| Supply Item Number | 1387 or 1678 |
| Specimen Type | Random urine |
| Preferred Volume | 30 mL |
| Emergency Minimum Volume | 15 mL |
| Collection Procedure | Collect a random urine specimen |
| Store and Transport | Ambient (room temperature)
|
| Required Patient Info | List last 5 days of prescription medicine taken by the patient |
| Stability | Room Temp 10 days Refrigerated 1 month |
| Unacceptable Condition | Blood, serum, or plasma samples |
| Reference Laboratory | PAML |
| Reference Lab Test Code | LCA code 910509 |
| CPT Codes | 80361, 80307, 80356, 80365, (HCPCS G0480) |
| Interface Order Code | 80101.Z213 |
| Billing Code | PM12017 |
| Test Schedule | Mon-Sat |
| Turnaround Time | 1-3 days |
| Method | Enzyme Immunoassay, Confirmations by GC/MS, LC/MS/MS, or GC/FID |
| Reference Ranges | | Title | Descriptor | Ranges | Units | | Alcohol Screen | Negative | < 20 | mg/dL | | Alcohol by GC/FID | Not Detected | < 8 | mg/dL | | Amp/Methamphetamine Screen | Negative | < 500 | ng/mL | | Amphetamines by GC/MS | Not Detected | < 250 | ng/mL | | Methamphetamine by GC/MS | Not Detected | < 250 | mg/mL | | D-Methamphetamine by GC/MS | Not Detected | < 250 | % | | L-Methamphetamine | Not Detected | < 250 | % | | Alternate Amphetamines Screen | Negative | < 500 | ng/mL | | MDMA by GC/MS | Not Detected | < 250 | ng/mL | | MDA by GC/MS | Not Detected | < 250 | ng/mL | | MDEA by GC/MS | Not Detected | < 250 | ng/mL | | Cannabinoids Screen (20) | Negative | < 20 | ng/mL | | Carboxy-THC by GC/MS | Not Detected | < 15 | ng/mL | | Cocaine Screen | Negative | < 150 | ng/mL | | Benzoylecgonine by GC/MS | Not Detected | < 100 | ng/mL | | Morphine by LC-MS/MS | Not Detected | < 50 | ng/mL | | Oxymorphone by LC-MS/MS | Not Detected | < 50 | ng/mL | | Hydromorphone by LC-MS/MS | Not Detected | < 50 | ng/mL | | Nor-Oxycodone by LC-MS/MS | Not Detected | < 50 | ng/mL | | Nor-Hydrocodone by LC-MS/MS | Not Detected | < 50 | ng/mL | | Oxycodone by LC-MS/MS | Not Detected | < 50 | ng/mL | | Codeine by LC-MS/MS | Not Detected | < 50 | ng/mL | | Heroin Metab (6AM) by LC-MS/MS | Not Detected | < 10 | ng/mL | | Hydrocodone by LC-MS/MS | Not Detected | < 50 | ng/mL | | Phencyclidine Screen | Negative | < 25 | ng/mL | | Phencyclidine by GC/MS | Not Detected | < 6 | ng/mL | | Propoxyphene Screen | Negative | < 300 | ng/mL | | Norpropoxyphene by GC/MS | Not Detected | < 80 | ng/mL | | Oxidants | Normal | < 200 | ug/mL | | Urine pH | Normal | 4.5-9.0 | | Urine Creatinine | Normal | > 19 | mg/dL | | Specific Gravity | Normal | 1.003-1.020 | | Glucose | Negative | < 20 | mg/dL |
|
| Compliance Remarks | This test was developed and its performance characteristics determined by PAML. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test. However, FDA approval or clearance is currently not required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. PAML is authorized under Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing. |
| Reflex Testing | | Reflex Condition | Reflex Test Name | Reflex CPT codes | Reflex Billing codes | | If any Analyte in panel positive | Reflex testing built into panel, no additional test codes required | Reflex testing built into panel, no additional CPT codes required | N/A | | If screen for Alcohol is positive | | | | | If screen for Amphetamines is positive | | If screen for Alternate Amphetamines is positive | | If screen for Cannabinoids (THC) is positive | | If screen for Cocaine is positive | | If screen for Propoxyphene is positive | | If screen for Phencyclidine is positive | |
|
